A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting-Reference-Cited by-同舟云学术

A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting

Published:2022-02-23 Issue:4 Volume:39 Page:1857-1870
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Blom Dirk J.^ORCID,Gaudet Daniel,Hegele Robert A.,Patel Dharmesh S.,Cegla Jaimini,Kolovou Genovefa,Marin Luis Masana

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-02031-y.pdf

Reference31 articles.

1. Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the european atherosclerosis society. Eur Heart J. 2014;35(32):2146–57. doi:https://doi.org/10.1093/eurheartj/ehu274.

2. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1(6):445–66. https://doi.org/10.1002/humu.1380010602.

3. Robinson JG. Management of familial hypercholesterolemia: a review of the recommendations from the national lipid association expert panel on familial hypercholesterolemia. J Manag Care Pharm. 2013;19(2):139–49.

4. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34(45):3478–90. https://doi.org/10.1093/eurheartj/eht273.

5. Santos RD, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, et al. Long-term evolocumab in patients with familial hypercholesterolemia. J Am Coll Cardiol. 2020;75(6):565–74. https://doi.org/10.1016/j.jacc.2019.12.020.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapies for refractory hypercholesterolemia: a narrative review;Future Cardiology;2024-04-25

2. Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events;Pharmacology & Therapeutics;2023-10

3. Advances in Treatment of Dyslipidemia;International Journal of Molecular Sciences;2023-08-27

4. Genotype–phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia;Current Opinion in Lipidology;2023-04-01

5. Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review;Nutrients;2023-03-21